Argenx Se (ARGX) Total Current Liabilities (2015 - 2026)

Argenx Se (ARGX) posted quarterly Total Current Liabilities of $1.6 billion for Q2 2026, down 99.85% year-on-year from $1041.9 billion in Q2 2025, and up 19.32% on a QoQ basis from $1.3 billion in Q4 2025.

Argenx Se (ARGX) Total Current Liabilities (2015 - 2026) Analysis & Trends

Argenx Se (ARGX) has reported Total Current Liabilities for 12 consecutive years, with $1.6 billion the latest figure, recorded in Q2 2026.

  • Quarterly Total Current Liabilities fell 99.85% year-over-year to $1.6 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $1.6 billion (down 99.85% YoY) and the FY2025 annual result came in at $1.3 billion, up 97.04% from the prior year.
  • Total Current Liabilities improved to $1.6 billion in Q2 2026 per ARGX's latest filing, from $1.3 billion in the prior quarter.
  • Over the last five years, Total Current Liabilities for ARGX reached as high as $1041.9 billion in Q2 2025 and fell as low as $264.6 million in Q2 2022.
  • A 5-year average of $116.4 billion and a median of $499.6 million in 2024 frame the typical range for Total Current Liabilities.
  • Annual changes were most pronounced in 2025 — Total Current Liabilities surged 208435.53% — and 2026, when it plunged 99.85%.
  • Year by year, Total Current Liabilities stood at $302.3 million in 2022, then soared by 39.94% to $423.0 million in 2023, then jumped by 58.38% to $669.9 million in 2024, then surged by 97.04% to $1.3 billion in 2025, then grew by 19.32% to $1.6 billion in 2026.
  • According to Business Quant data, Total Current Liabilities over the past three periods registered $1.6 billion, $1.3 billion, and $1041.9 billion for Q2 2026, Q4 2025, and Q2 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 56.01 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 66.94 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1.81 Bn
4 NuCana 279.75 Bn 279.75 Bn - 6.38 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 3.88 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 5.11 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 1.58 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 289.60 Mn
10 Alnylam Pharmaceuticals 35.71 Bn 32.70 Bn 959.66 Mn 1.35 Bn

Historic Data

Download Data
DateValue
Jun 30, 2026 1.58 Bn
Dec 31, 2025 1.32 Bn
Jun 30, 2025 1,041.90 Bn
Dec 31, 2024 669.92 Mn
Jun 30, 2024 499.63 Mn
Dec 31, 2023 422.99 Mn
Jun 30, 2023 317.79 Mn
Dec 31, 2022 302.28 Mn
Jun 30, 2022 264.60 Mn
Dec 31, 2021 301.24 Mn
Jun 30, 2021 244.04 Mn
Dec 31, 2020 304.63 Mn
Jun 30, 2020 225.12 Mn
Dec 31, 2019 182.02 Mn
Jun 30, 2019 116.51 Mn
Dec 31, 2018 45.58 Mn
Jun 30, 2018 39.02 Mn
Dec 31, 2017 35.38 Mn
Jun 30, 2017 50.85 Mn
Dec 31, 2016 46.65 Mn